#forFCS - Twitter Hashtag

4 months ago

Today, we announced that the Therapeutic Goods Administration has approved our siRNA therapy for use in the treatment of adults with Familial Chylomicronemia Syndrome (FCS) in Australia. Read the full announcement here: https://t.co/k6jmpC7NV0 #RareDisease #ForFCS

2

42

4

0

3K

ArrowheadPharma @ArrowheadPharma

6 months ago

By elevating patient voices and increasing awareness on #RareDiseaseDay and every day, we can help drive understanding, earlier recognition and better support for people living with FCS and HoFH. #ForFCS #FCSAwareness #RareDisease

ArrowheadPharma's tweet photo. By elevating patient voices and increasing awareness on #RareDiseaseDay and every day, we can help drive understanding, earlier recognition and better support for people living with FCS and HoFH.

#ForFCS #FCSAwareness #RareDisease https://t.co/GrWz02ibFw

0

14

0

456

ArrowheadPharma @ArrowheadPharma

8 months ago

Breaking news: Health Canada has approved our therapy as an adjunct to diet to lower triglycerides in adults with Familial Chylomicronemia Syndrome (FCS) where standard triglyceride-lowering therapies were inadequate. Learn more: https://t.co/5CbABFbf49 #RareDisease #ForFCS

4

22

0

1K

ArrowheadPharma @ArrowheadPharma

9 months ago

People with consistent fasting triglycerides >500 mg/dL are in an established acute pancreatitis-risk danger zone. Those with FCS should aim to keep #triglycerides below 500 mg/dL, per expert guidelines. Learn more at https://t.co/fkgcOVPMt5 #FCSAwareness #ForFCS

ArrowheadPharma's tweet photo. People with consistent fasting triglycerides >500 mg/dL are in an established acute pancreatitis-risk danger zone.
Those with FCS should aim to keep #triglycerides below 500 mg/dL, per expert guidelines.
Learn more at https://t.co/fkgcOVPMt5
#FCSAwareness #ForFCS https://t.co/0xfUop6Lj4

0

25

0

664

ArrowheadPharma @ArrowheadPharma

9 months ago

“I want to help people not have to go through what I went through.” — Scott, living with FCS. This Thanksgiving, we’re thankful for every patient who shares their FCS story to support others. Do you have FCS? Submit your story on our website: https://t.co/10QCQP0Wzm #ForFCS

3

18

0

526

ArrowheadPharma @ArrowheadPharma

10 months ago

It’s #FCSAwarenessDay — and this rare disease needs more visibility. FCS is often misunderstood or missed entirely. Our latest webinar features Julie & Scott sharing their lived experience: https://t.co/gObrEgBIPZ #ForFCS #FCSAwareness

ArrowheadPharma's tweet photo. It’s #FCSAwarenessDay — and this rare disease needs more visibility. FCS is often misunderstood or missed entirely. Our latest webinar features Julie & Scott sharing their lived experience: https://t.co/gObrEgBIPZ

#ForFCS #FCSAwareness https://t.co/r4DfNMHc7W

2

19

3

1

866

ArrowheadPharma @ArrowheadPharma

10 months ago

Behind every Familial Chylomicronemia Syndrome (FCS) diagnosis is the challenge of balancing physical health and mental wellbeing. In our webinar, Julie shares how she copes with the stress of living with FCS: https://t.co/gObrEgBIPZ #ForFCS #FCSAwareness

1

18

0

529

ArrowheadPharma @ArrowheadPharma

12 months ago

Triglycerides are one of the three key types of fats (lipids)in our blood — triglycerides, phospholipids and sterols —and are especially critical for patients living with Familial Chylomicronemia Syndrome(FCS). Learn more: https://t.co/fkgcOVPMt5 #ForFCS #FCSAwareness

3

24

1

835

ArrowheadPharma @ArrowheadPharma

over 1 year ago

Are you ready to discuss all things lipids in Miami at the #NLASessions this weekend? Come find Andy Davis and our Arrowheads at booth #207 to learn more about the NLA Guidelines for lipid and #triglyceride management. #WeAreArrowhead #ForFCS #NLA25

0

9

1

0

545

ArrowheadPharma @ArrowheadPharma

over 1 year ago

Familial Chylomicronemia Syndrome (FCS) is a rare disease that impacts 1-13 people per million. We’re proud to announce that last week, on #RareDiseaseDay we launched our patient resource, https://t.co/knj1Kg3sqD, that elevates patient voices and education #forFCS.

ArrowheadPharma's tweet photo. Familial Chylomicronemia Syndrome (FCS) is a rare disease that impacts 1-13 people per million. We’re proud to announce that last week, on #RareDiseaseDay we launched our patient resource, https://t.co/knj1Kg3sqD, that elevates patient voices and education #forFCS. https://t.co/o6H0DxkNFy

3

19

0

686

ArrowheadPharma @ArrowheadPharma

over 1 year ago

At Arrowhead we're dedicated to pursuing the development of therapies that have the potential to improve the lives of patients living with rare diseases. Learn more about them and our pipeline: https://t.co/g2Xi39Hnr9 #ForFCS #RareDiseaseMonth #RareDiseaseDay #FCSAwareness #HoFH

9

26

0

1

2K

ArrowheadPharma @ArrowheadPharma

over 1 year ago

Experiences shared by the #FCS community strengthen our commitment to the work we do. Thank you to advocacy groups like @livingwithfcs @NatPancFdn @ActionFCS and @fhpatienteurope who educate and inspire us. Here’s to more progress in 2025 #forFCS!

6

21

0

1

912

ArrowheadPharma @ArrowheadPharma

almost 2 years ago

Its #FCSAwareness Day, let’s raise awareness, drive research, & support those affected by Familial Chylomicronemia Syndrome (FCS). We heard from special guests on their experiences living with FCS. Together, we can make the invisible visible #ForFCS. More: https://t.co/AEsQw9v7OG